KELLI DUCOTE: Open Payments
NPI 1518746098 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 72 payments from 14 companies in 2025. Trend: 2023 $88 · 2024 $1,401 · 2025 $1,681
Food & beverage: $1,602Education: $79
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $297 |
| GlaxoSmithKline, LLC. | 15 | $258 |
| AstraZeneca Pharmaceuticals LP | 11 | $206 |
| Verona Pharma, Inc. | 7 | $181 |
| Regeneron Healthcare Solutions, Inc. | 5 | $154 |
| Viatris Specialty LLC | 5 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $96 |
| Grifols USA, LLC | 3 | $84 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Amgen Inc. | 3 | $60 |
Products named: DUPIXENT, Ohtuvayre, NUCALA, FASENRA, TEZSPIRE, YUPELRI, TRELEGY ELLIPTA, Prolastin-C Liquid.
Industry payments across LA — which companies pay providers there.
